![Ipsen resized 355x200.jpg](https://www.bioindustry.org/static/derivatives/jobdetailscompanylogo_dd64811c02712599828cc4c462858531/29689113-90cb-4f31-95a6e6195d474902.jpg)
Ipsen Biopharm Ltd
Ipsen also has a well-established Consumer Healthcare business.
With total sales close to €2.5 billion in 2020, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,700 employees worldwide.